News
-
Organ donation >10K
Wednesday | Feb 21 2018FEDERAL Minister for Aged Care and Indigenous Health Ken Wyatt has announced that the national organ donation program has saved more than 10,000 lives in 2017, and improved the lives of 1,675 Australians with a further 9,600 benefiting from eye and tissue transplants.
-
CW nets major partnership
Wednesday | Feb 21 2018AUSTRALIAN pharmacy discount retail group Chemist Warehouse has again linked with Beach Netball ("It's netball, but not as you know it") as a major partner and is gearing up to support the upcoming 2018 series across the country.
-
EBOS H1 earnings up 15.6%
Wednesday | Feb 21 2018ASX-LISTED marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products EBOS, has announced a record interim unaudited net profit of $76.7m for the six months to 31 Dec 2017, with EBITDA up 15.6% and net profit after tax up 11.5%.
-
Gabapentinoid abuse up
Wednesday | Feb 21 2018THE US Food and Drug Administration (FDA) is actively looking into the potential misuse and abuse of gabapentinoids, a class of drugs that includes Pfizer's Neurontin (gabapentin) and Lyrica (pregabalin), which have been approved to treat a number of conditions such as postherpetic neuralgia, fibromyalgia and neuropathic pain.
-
-
Dispensary Corner 20 Feb 18
Tuesday | Feb 20 2018SUFFERERS of conditions like irritable bowel syndrome beware - it might get you involved in a brouhaha at 40,000 feet.
-
Meds reconciliation
Tuesday | Feb 20 2018HIGHER accuracy of complex medication reconciliation can be achieved through improved design of electronic tools according to new work out of the USA published in the Journal of the American Medical Informatics Association.
-
Metformin XR recall
Tuesday | Feb 20 2018APOTEX, in consultation with the TGA, is recalling one batch of APO-Metformin XR 1000 mg tablets (batch number E16539) due to potential contamination.
-
Arthrem safe
Tuesday | Feb 20 2018FOLLOWING the NZ Medsafe "potential risk" alert around joint-support product Arthrem, from Promisia and marketed by Pharmabroker, Promisia explains it is safe when taken "strictly as directed" - see the full story on two pages after the news.
-
Mundipharma buys Tolmar for Eligard(R)
Tuesday | Feb 20 2018FOLLOWING several months of comprehensive due diligence and negotiation, Mundipharma has announced the acquisition of specialist pharmaceutical company, Tolmar Australia, supplementing its own oncology protfolio by including exclusive distribution rights for the oncology medication Eligard and Bi-Eligard (leuprorelin acetate) in Australia and New Zealand.
